We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
+11.26%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$861M
AUM Growth
–
Cap. Flow
+$823M
Cap. Flow
% of AUM
95.57%
Top 10 Holdings %
Top 10 Hldgs %
61.89%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HNT
HEALTH NET INC
HNT
|
+$64M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$62.5M |
| 3 |
General Motors
GM
|
+$61.5M |
| 4 |
ATI
ATI
|
+$59.2M |
| 5 |
AET
Aetna Inc
AET
|
+$57.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.41% |
| 2 | Consumer Discretionary | 20.31% |
| 3 | Industrials | 15.34% |
| 4 | Financials | 11.51% |
| 5 | Technology | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSP
1
DELISTED
HOSPIRA INC
HSP
| $70.9M | 8.23% |
+1,850,000
| New | +$62.5M |
|
|
HNT
2
DELISTED
HEALTH NET INC
HNT
| $67.6M | 7.86% |
+2,125,000
| New | +$64M |
|
|
3
General Motors
GM
$80.4B
| $64.6M | 7.51% |
+1,940,000
| New | +$61.5M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $62M | 7.2% |
+975,000
| New | +$57.3M |
|
|
5
ATI
ATI
$25.6B
| $55.3M | 6.42% |
+2,100,000
| New | +$59.2M |
|
|
QVCGA
6
DELISTED
QVC Group Inc Series A
QVCGA
| $49.2M | 5.72% |
+52,088
| New | +$47M |
|
7
Boston Scientific
BSX
$69.5B
| $46.4M | 5.38% |
+5,000,000
| New | +$42.4M |
|
8
Adobe
ADBE
$99.5B
| $42.1M | 4.9% |
+925,000
| New | +$41M |
|
|
LO
9
PUT
DELISTED
LORILLARD INC COM STK
LO
| $37.6M | 4.36% |
+860,000
| New | +$36.8M |
|
|
GTS
10
DELISTED
Triple-S Management Corporation
GTS
| $37.1M | 4.31% |
+1,818,249
| New | +$34.2M |
|
|
NWY
11
DELISTED
New York & Co Inc
NWY
| $31.8M | 3.69% |
+5,000,000
| New | +$24.8M |
|
|
AH
12
DELISTED
Accretive Health
AH
| $31.5M | 3.65% |
+2,910,000
| New | +$30.6M |
|
13
Huntsman Corp
HUN
$1.71B
| $30.6M | 3.56% |
+1,850,000
| New | +$33.8M |
|
14
Brookdale Senior Living
BKD
$3.49B
| $30.4M | 3.53% |
+1,150,000
| New | +$31.7M |
|
15
Acacia Research
ACTG
$428M
| $28.3M | 3.28% |
+1,265,054
| New | +$31.8M |
|
|
LORL
16
DELISTED
Loral Space and Communications, Inc.
LORL
| $23.4M | 2.72% |
+390,000
| New | +$23.9M |
|
|
VRNT
17
DELISTED
Verint Systems
VRNT
| $21.3M | 2.47% |
+1,177,800
| New | +$20.5M |
|
|
BODY
18
DELISTED
BODY CENTRAL CORP COM STK
BODY
| $20M | 2.32% |
+1,500,000
| New | +$16.6M |
|
|
MCGC
19
DELISTED
MCG CAP CORP
MCGC
| $16.9M | 1.97% |
+3,250,000
| New | +$16.3M |
|
|
LOV
20
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $14.6M | 1.7% |
+1,730,855
| New | +$13.3M |
|
21
Xerox
XRX
$387M
| $12.4M | 1.44% |
+519,915
| New | +$12.1M |
|
|
GCVRZ
22
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $11.1M | 1.29% |
+5,742,288
| New | +$10.1M |
|
|
ALIM
23
DELISTED
Alimera Sciences
ALIM
| $9.27M | 1.08% |
+126,667
| New | +$7.31M |
|
24
Lear
LEA
$6.54B
| $7.56M | 0.88% |
+125,000
| New | +$7.21M |
|
25
LiveRamp
RAMP
$2.3B
| $7.39M | 0.86% |
+325,976
| New | +$6.83M |
|
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for North Run Capital, which disclosed 32 positions worth $861M. Its ten largest holdings account for 62% of the portfolio.
Its largest position is HEALTH NET INC: 2,125,000 shares worth $67.6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, followed by Consumer Discretionary and Industrials.
- North Run Capital's largest Q2 2013 buy was HEALTH NET INC: 2,125,000 shares worth $67.6M.
- North Run Capital's ten largest holdings make up 62% of its $861M portfolio in Q2 2013.
- North Run Capital disclosed 32 positions in Q2 2013, its first 13F filing on record.
Based on North Run Capital's 13F filing for Q2 2013, filed 9 Aug 2013.